Daniel Caldeira1,2,3, Bárbara Rodrigues2, Cláudio David1,2,3, João Costa2,3, Fausto J Pinto1, Joaquim J Ferreira2,3. 1. Faculdade de Medicina, Universidade de Lisboa. Avenida Professor Egas Moniz, Serviço de Cardiologia, Hospital Universitário de Santa Maria (CHLN), CAML, Centro Cardiovascular da Universidade de Lisboa - CCUL, Lisboa, Portugal. 2. Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina, Avenida Professor Egas Moniz, Universidade de Lisboa, Lisboa, Portugal. 3. Instituto de Medicina Molecular, Faculdade de Medicina, Avenida Professor Egas Moniz, Universidade de Lisboa, Lisboa, Portugal.
Abstract
Introduction: Influenza vaccination may be beneficial in coronary disease patients; however the infection and vaccination are associated with acute inflammation, a trigger of cardiovascular events. We aimed to review the risk of myocardial infarction (MI) associated with Influenza infection and the safety of vaccination in self-controlled case series (SCCS). Methods: We performed a systematic review with meta-analysis of SCCS studies to evaluate the risk of MI associated with Influenza infection/vaccination. Database search was performed in August/2018. The data were reported using the incident rate ratio (IRR) and 95% confidence interval (95%CI). Results: three studies for Influenza infection and two studies for Influenza vaccination were eligible. The risk of MI following an Influenza infection was significantly increased in the first 3 days (IRR 5.79; 95%CI: 3.59-9.38) and between 4-7 days (IRR 4.52; 95%CI: 2.80-7.32). In the first 4 weeks following the Influenza vaccination, there was a significant decrease of MI risk (IRR 0.84, 95%CI: 0.78-0.91).Conclusions: Short-term MI risk in Influenza infection is significantly increased, with a low-to-moderate confidence in the pooled evidence. The Influenza vaccine was safe regarding the short-term risk for MI, and the risk reduction is possibly related to a healthy period bias.
Introduction: Influenza vaccination may be beneficial in coronary diseasepatients; however the infection and vaccination are associated with acute inflammation, a trigger of cardiovascular events. We aimed to review the risk of myocardial infarction (MI) associated with Influenza infection and the safety of vaccination in self-controlled case series (SCCS). Methods: We performed a systematic review with meta-analysis of SCCS studies to evaluate the risk of MI associated with Influenza infection/vaccination. Database search was performed in August/2018. The data were reported using the incident rate ratio (IRR) and 95% confidence interval (95%CI). Results: three studies for Influenza infection and two studies for Influenza vaccination were eligible. The risk of MI following an Influenza infection was significantly increased in the first 3 days (IRR 5.79; 95%CI: 3.59-9.38) and between 4-7 days (IRR 4.52; 95%CI: 2.80-7.32). In the first 4 weeks following the Influenza vaccination, there was a significant decrease of MI risk (IRR 0.84, 95%CI: 0.78-0.91).Conclusions: Short-term MI risk in Influenza infection is significantly increased, with a low-to-moderate confidence in the pooled evidence. The Influenza vaccine was safe regarding the short-term risk for MI, and the risk reduction is possibly related to a healthy period bias.
Authors: Muhammad Shahzeb Khan; Izza Shahid; Stefan D Anker; Scott D Solomon; Orly Vardeny; Erin D Michos; Gregg C Fonarow; Javed Butler Journal: BMC Med Date: 2020-12-18 Impact factor: 8.775
Authors: Dawid Pieper; Irma Hellbrecht; Linlu Zhao; Clemens Baur; Georgia Pick; Sarah Schneider; Thomas Harder; Kelsey Young; Andrea C Tricco; Ella Westhaver; Matthew Tunis Journal: Syst Rev Date: 2022-08-22
Authors: Joshua Nealon; Nieves Derqui; Caroline de Courville; Tor Biering-Sørensen; Benjamin J Cowling; Harish Nair; Sandra S Chaves Journal: Open Forum Infect Dis Date: 2022-07-21 Impact factor: 4.423